Overview
David Ashley is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Ashley is rated as an Elite provider by MediFind in the treatment of Brain Tumor. His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri. Dr. Ashley is currently accepting new patients.
His clinical research consists of co-authoring 137 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 61 articles and participated in 3 clinical trials in the study of Brain Tumor.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- POS
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
20 Duke Medicine Cir, Durham, NC 27710
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
7 Clinical Trials
Duke Cancer Center
I am an academic adult and pediatric neuro-oncologist who helps lead The Preston Robert Tisch Brain Tumor Center at Duke. I am the author of more than 500 peer-reviewed articles, reviews, and book chapters, and I have presented extensively at both international and national meetings. I am a committed educator who is a member of the executive and super-executive committees of the Duke University School of Medicine, which are responsible for the recruitment, screening and selection of medical students. I have reviewed grants for the National Institutes of Health for over 15 years, in a spectrum of different study sections. I am the senior editor of CNS Oncology and a reviewer for over 25 academic journals. I serve on the advisory board of a number of organizations, including Voices Against Brain Cancer, the Tug McGraw Foundation, Pinnacle Care, the Pediatric Brain Tumor Foundation, the National Children’s Cancer Society, and the American Brain Tumor Association. Dr. Friedman is rated as an Elite provider by MediFind in the treatment of Brain Tumor. His top areas of expertise are Glioma, Astrocytoma, Glioblastoma, and Brain Tumor.
Duke Health Integrated Practice Inc
Carey Anders is an Oncologist in Durham, North Carolina. Dr. Anders is rated as an Elite provider by MediFind in the treatment of Brain Tumor. Her top areas of expertise are Breast Cancer, Brain Tumor, Triple-Negative Breast Cancer, and HER-2 Positive Breast Cancer. Dr. Anders is currently accepting new patients.
Duke Cancer Center
As a cancer doctor, I strive to provide the kind of care that I would want for my own family. My aim is to use my expertise, knowledge, and understanding of the human condition to empower patients. While scientific knowledge and approaches are at the core of what I do, I find it important to aim to integrate the human context into what my team and I offer patients and their families. Having lived, trained, and worked in different countries, including Australia, the United Kingdom, the Netherlands, and the United States, I have developed unique insights into the practice of medicine and cancer care around the world. These experiences have given me a broader perspective and helped inform my approach to individualized patient care. I see my ability to help patients as a privilege, and I do get enormous pleasure from being able to help. When not working, I am an avid reader and enjoy running, cycling, and spending time with my family. Dr. Khasraw is rated as an Elite provider by MediFind in the treatment of Brain Tumor. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Hip Replacement.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- AstrocytomaDr. Ashley isElite. Learn about Astrocytoma.
- Brain TumorDr. Ashley isElite. Learn about Brain Tumor.
- GlioblastomaDr. Ashley isElite. Learn about Glioblastoma.
- GliomaDr. Ashley isElite. Learn about Glioma.
- Gliomatosis CerebriDr. Ashley isElite. Learn about Gliomatosis Cerebri.
- Distinguished
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Ashley isDistinguished. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Embryonal Tumor with Multilayered RosettesDr. Ashley isDistinguished. Learn about Embryonal Tumor with Multilayered Rosettes.
- GliosarcomaDr. Ashley isDistinguished. Learn about Gliosarcoma.
- NeuroepitheliomaDr. Ashley isDistinguished. Learn about Neuroepithelioma.
- OligodendrogliomaDr. Ashley isDistinguished. Learn about Oligodendroglioma.
- Advanced
- EpendymomaDr. Ashley isAdvanced. Learn about Ependymoma.
- GangliogliomaDr. Ashley isAdvanced. Learn about Ganglioglioma.
- MedulloblastomaDr. Ashley isAdvanced. Learn about Medulloblastoma.
- Metastatic Brain TumorDr. Ashley isAdvanced. Learn about Metastatic Brain Tumor.
- Pediatric Low-Grade Glioma (pLGG)Dr. Ashley isAdvanced. Learn about Pediatric Low-Grade Glioma (pLGG).
- Posterior Fossa TumorDr. Ashley isAdvanced. Learn about Posterior Fossa Tumor.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Ashley isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Adult Soft Tissue SarcomaDr. Ashley isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Ataxia-TelangiectasiaDr. Ashley isExperienced. Learn about Ataxia-Telangiectasia.
- Brain Stem CancerDr. Ashley isExperienced. Learn about Brain Stem Cancer.
- Breast CancerDr. Ashley isExperienced. Learn about Breast Cancer.
- Diffuse Midline Glioma H3 K27M-MutantDr. Ashley isExperienced. Learn about Diffuse Midline Glioma H3 K27M-Mutant.


